Sectors & IndustriesHealthcareHealthcare Plans

Best Healthcare Plan Stocks to Buy Now (2024)

Top healthcare plan stocks in 2024 ranked by overall Zen Score. See the best healthcare plan stocks to buy now, according to analyst forecasts for the healthcare plans industry.

According to Zen Score, the 3 best healthcare plan stocks to buy right now are:

Molina Healthcare (NYSE:MOH) is the top healthcare plan stock with a Zen Score of 62, which is 21 points higher than the healthcare plan industry average of 41. It passed 21 out of 33 due diligence checks and has strong fundamentals. Molina Healthcare has seen its stock return 2.87% over the past year, overperforming other healthcare plan stocks by 4 percentage points.

Molina Healthcare has an average 1 year price target of $374.40, an upside of 12.99% from Molina Healthcare's current stock price of $331.36.

Molina Healthcare stock has a consensus Buy recommendation according to Wall Street analysts. Of the 10 analysts covering Molina Healthcare, 40% have issued a Strong Buy rating, 10% have issued a Buy, 50% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

Humana (NYSE:HUM) is the second best healthcare plan stock with a Zen Score of 54, which is 13 points higher than the healthcare plan industry average of 41. It passed 19 out of 38 due diligence checks and has strong fundamentals. Humana has seen its stock lose -50.5% over the past year, underperforming other healthcare plan stocks by -50 percentage points.

Humana has an average 1 year price target of $335.71, an upside of 38.85% from Humana's current stock price of $241.78.

Humana stock has a consensus Buy recommendation according to Wall Street analysts. Of the 17 analysts covering Humana, 17.65% have issued a Strong Buy rating, 17.65% have issued a Buy, 58.82% have issued a hold, while 5.88% have issued a Sell rating, and 0% have issued a Strong Sell.

Elevance Health (NYSE:ELV) is the third best healthcare plan stock with a Zen Score of 50, which is 9 points higher than the healthcare plan industry average of 41. It passed 18 out of 38 due diligence checks and has strong fundamentals. Elevance Health has seen its stock return 14.93% over the past year, overperforming other healthcare plan stocks by 16 percentage points.

Elevance Health has an average 1 year price target of $600.85, an upside of 20.59% from Elevance Health's current stock price of $498.25.

Elevance Health stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 13 analysts covering Elevance Health, 84.62% have issued a Strong Buy rating, 7.69% have issued a Buy, 7.69% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

Out of 5 healthcare plan stocks that have issued dividends in the past year, the 3 healthcare plan stocks with the highest dividend yields are:

Cvs Health (NYSE:CVS) has an annual dividend yield of 4.13%, which is 2 percentage points higher than the healthcare plan industry average of 1.96%. Cvs Health's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Cvs Health's dividend has shown consistent growth over the last 10 years.

Cvs Health's dividend payout ratio of 46.1% indicates that its dividend yield is sustainable for the long-term.

Cigna Group (NYSE:CI) has an annual dividend yield of 1.59%, which is the same as the healthcare plan industry average of 1.96%. Cigna Group's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Cigna Group's dividend has shown consistent growth over the last 10 years.

Cigna Group's dividend payout ratio of 40.9% indicates that its dividend yield is sustainable for the long-term.

Humana (NYSE:HUM) has an annual dividend yield of 1.46%, which is the same as the healthcare plan industry average of 1.96%. Humana's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Humana's dividend has shown consistent growth over the last 10 years.

Humana's dividend payout ratio of 24.9% indicates that its dividend yield is sustainable for the long-term.

Healthcare plan stocks were down -0.58% in the last day, and down -3.75% over the last week.

We couldn't find a catalyst for why healthcare plan stocks are down.

Based on WallStreetZen's Valuation Score, the 3 most undervalued healthcare plan stocks right now are:

Humana (NYSE:HUM) is the most undervalued healthcare plan stock based on WallStreetZen's Valuation Score. Humana has a valuation score of 57, which is 28 points higher than the healthcare plan industry average of 29. It passed 4 out of 7 valuation due diligence checks.

Humana's stock has dropped -50.5% in the past year. It has underperformed other stocks in the healthcare plan industry by -50 percentage points.

Centene (NYSE:CNC) is the second most undervalued healthcare plan stock based on WallStreetZen's Valuation Score. Centene has a valuation score of 57, which is 28 points higher than the healthcare plan industry average of 29. It passed 4 out of 7 valuation due diligence checks.

Centene's stock has gained 5.57% in the past year. It has overperformed other stocks in the healthcare plan industry by 6 percentage points.

Cvs Health (NYSE:CVS) is the third most undervalued healthcare plan stock based on WallStreetZen's Valuation Score. Cvs Health has a valuation score of 57, which is 28 points higher than the healthcare plan industry average of 29. It passed 4 out of 7 valuation due diligence checks.

Cvs Health's stock has dropped -9.14% in the past year. It has underperformed other stocks in the healthcare plan industry by -8 percentage points.